Question 1

How does IDS Scheer (Czechia) rank in research?

Accepted Answer

IDS Scheer (Czechia) ranks #30,203 of 34,923 institutions worldwide on research quality over all time, and #145 of 198 in the Czechia.

Question 2

Who are the top researchers at IDS Scheer (Czechia)?

Accepted Answer

Ranked on the quality score, Helmut Kruppke, Peter Mattheis and Karl Wilhelm Ramler lead among researchers whose main affiliation is IDS Scheer (Czechia).

Question 3

What are the most cited papers from IDS Scheer (Czechia)?

Accepted Answer

The most cited paper from IDS Scheer (Czechia) is "Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies" (Jacquelyn W. Zimmerman, Hugo Jimenez, Michael J. Pennison et al., 2013), with 77 citations. Next come "E‐business process networks – successful value chains through standards" (60) and "The Process of Business Process Management" (53).

Question 4

Which research topics does IDS Scheer (Czechia) publish most on?

Accepted Answer

By volume in 2022-now: Aging, Elder Care, and Social Issues, Spectroscopy and Chemometric Analyses, American Constitutional Law and Politics and French Urban and Social Studies.

Question 5

Which keywords describe research at IDS Scheer (Czechia)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Information Technology, Customer Relationship Management, Digital Capital, Value Chains, Big Data, Business Process Management, Workflow Mining and Sustainable Development.

Question 6

Which fields of science does IDS Scheer (Czechia) work in?

Accepted Answer

In all years, 70% of research at IDS Scheer (Czechia) is in Social Sciences, 20% in Physical Sciences. Its largest fields are Business, Management and Accounting (47%), Social Sciences (14%), Engineering (11%). It does 3.2× the world's share of Social Sciences.

Question 7

Is IDS Scheer (Czechia)'s research output growing?

Accepted Answer

Output in 2022-2025 was 12% lower than in 2018-2021.

Discussion